Clinical Trial

An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This a phase 1, partially blinded, randomized, crossover study to determine the pharmacokinetics (PK) and QT/QTc interval of study drug (ESK-001) in healthy volunteer participants,
Trial Details
NCT Number NCT07378579
Lead Sponsor Alumis Inc
Conditions Healthy Volunteer
Enrollment 52 participants
Start Date 2024-06-21
Primary Completion 2024-08-31 (estimated)
Study Completion 2024-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-30